DUX4 and Facioscapulohumeral dystrophy: To compare the efficacy of our system in screening FSHD therapeutics to previously used muscle cell models, we assayed the effect of several DUX4 inhibitors in D4Z4-S5 HeLa cells and identified the p38 inhibitor losmapimod as a repressor of GFP expression.